PEOPLE - Changes at AtriCure:
This article was originally published in Clinica
Executive Summary
David Drachman, president and CEO of AtriCure, a Cincinnati, Ohio-based medical device company focused on technology to block the causes of atrial fibrillation during open heart surgery, is to be interim CFO for the company from August 18 2006. The current CFO, Thomas Etergino, will be leaving to return to his native New York for personal reasons.